{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:20:55Z","timestamp":1790623255812,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1106411"],"award-info":[{"award-number":["APP1106411"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1184879"],"award-info":[{"award-number":["APP1184879"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1154347"],"award-info":[{"award-number":["APP1154347"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002301","name":"Eesti Teadusagentuur","doi-asserted-by":"publisher","award":["PRG1154"],"award-info":[{"award-number":["PRG1154"]}],"id":[{"id":"10.13039\/501100002301","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Ministry of Science, Technology and Innovation | Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","award":["0116005600"],"award-info":[{"award-number":["0116005600"]}],"id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Arthritogenic alphaviruses are positive-strand RNA viruses that cause debilitating musculoskeletal diseases affecting millions worldwide. A recent discovery identified the four-and-a-half-LIM domain protein 1 splice variant A (FHL1A) as a crucial host factor interacting with the hypervariable domain (HVD) of chikungunya virus (CHIKV) nonstructural protein 3 (nsP3). Here, we show that acute and chronic chikungunya disease in humans correlates with elevated levels of FHL1. We generated FHL1\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    mice, which when infected with CHIKV or o\u2019nyong-nyong virus (ONNV) displayed reduced arthritis and myositis, fewer immune infiltrates, and reduced proinflammatory cytokine\/chemokine outputs, compared to infected wild-type (WT) mice. Interestingly, disease signs were comparable in FHL1\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    and WT mice infected with arthritogenic alphaviruses Ross River virus (RRV) or Mayaro virus (MAYV). This aligns with pull-down assay data, which showed the ability of CHIKV and ONNV nsP3 to interact with FHL1, while RRV and MAYV nsP3s did not. We engineered a CHIKV mutant unable to bind FHL1 (CHIKV-\u0394FHL1), which was avirulent in vivo. Following inoculation with CHIKV-\u0394FHL1, mice were protected from disease upon challenge with CHIKV and ONNV, and viraemia was significantly reduced in RRV- and MAYV-challenged mice. Targeting FHL1-binding as an approach to vaccine design could lead to breakthroughs in mitigating alphaviral disease.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-42330-2","type":"journal-article","created":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T06:02:29Z","timestamp":1698300149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["FHL1 promotes chikungunya and o\u2019nyong-nyong virus infection and pathogenesis with implications for alphavirus vaccine design"],"prefix":"10.1038","volume":"14","author":[{"given":"Wern Hann","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng L.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla N. O.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2169-7463","authenticated-orcid":false,"given":"Lucas S.","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Kueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7539-7581","authenticated-orcid":false,"given":"Marco J.","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3037-1568","authenticated-orcid":false,"given":"Sandra","family":"Koit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-4965","authenticated-orcid":false,"given":"Sainan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6277-8887","authenticated-orcid":false,"given":"Andrew R.","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro M.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Merits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roque P.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3877-9772","authenticated-orcid":false,"given":"Nicholas J. C.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3141-8410","authenticated-orcid":false,"given":"Suresh","family":"Mahalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,26]]},"reference":[{"key":"42330_CR1","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1016\/S1473-3099(20)30491-6","volume":"21","author":"A Zaid","year":"2021","unstructured":"Zaid, A. et al. Arthritogenic alphaviruses: epidemiological and clinical perspective on emerging arboviruses. Lancet Infect. Dis. 21, e123\u2013e133 (2021).","journal-title":"Lancet Infect. Dis."},{"key":"42330_CR2","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/art.40403","volume":"70","author":"A Zaid","year":"2018","unstructured":"Zaid, A. et al. Chikungunya arthritis: implications of acute and chronic inflammation mechanisms on disease management. Arthritis Rheumatol. 70, 484\u2013495 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"42330_CR3","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.antiviral.2009.10.008","volume":"85","author":"SC Weaver","year":"2010","unstructured":"Weaver, S. C. & Reisen, W. K. Present and future arboviral threats. Antiviral Res. 85, 328\u2013345 (2010).","journal-title":"Antiviral Res."},{"key":"42330_CR4","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/S1473-3099(16)30385-1","volume":"17","author":"FJ Burt","year":"2017","unstructured":"Burt, F. J. et al. Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect. Dis. 17, e107\u2013e117 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"42330_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0140-6736(11)60281-X","volume":"379","author":"FJ Burt","year":"2012","unstructured":"Burt, F. J., Rolph, M. S., Rulli, N. E., Mahalingam, S. & Heise, M. T. Chikungunya: a re-emerging virus. Lancet 379, 662\u2013671 (2012).","journal-title":"Lancet"},{"key":"42330_CR6","first-page":"762","volume":"138","author":"J Bettadapura","year":"2013","unstructured":"Bettadapura, J., Herrero, L. J., Taylor, A. & Mahalingam, S. Approaches to the treatment of disease induced by chikungunya virus. Indian J. Med. Res. 138, 762\u2013765 (2013).","journal-title":"Indian J. Med. Res."},{"key":"42330_CR7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.12688\/f1000research.12461.1","volume":"6","author":"K Tharmarajah","year":"2017","unstructured":"Tharmarajah, K., Mahalingam, S. & Zaid, A. Chikungunya: vaccines and therapeutics. F1000Res. 6, 2114 (2017).","journal-title":"F1000Res"},{"key":"42330_CR8","doi-asserted-by":"publisher","first-page":"e1007239","DOI":"10.1371\/journal.ppat.1007239","volume":"15","author":"Y Gao","year":"2019","unstructured":"Gao, Y., Goonawardane, N., Ward, J., Tuplin, A. & Harris, M. Multiple roles of the non-structural protein 3 (nsP3) alphavirus unique domain (AUD) during Chikungunya virus genome replication and transcription. PLoS Pathog 15, e1007239 (2019).","journal-title":"PLoS Pathog"},{"key":"42330_CR9","doi-asserted-by":"publisher","first-page":"16307","DOI":"10.1074\/jbc.M116.732412","volume":"291","author":"H Tossavainen","year":"2016","unstructured":"Tossavainen, H., Aitio, O., Hellman, M., Saksela, K. & Permi, P. Structural basis of the high affinity interaction between the alphavirus nonstructural protein-3 (nsP3) and the SH3 domain of amphiphysin-2. J. Biol. Chem. 291, 16307\u201316317 (2016).","journal-title":"J. Biol. Chem."},{"key":"42330_CR10","doi-asserted-by":"publisher","first-page":"10088","DOI":"10.1128\/JVI.01011-08","volume":"82","author":"R Gorchakov","year":"2008","unstructured":"Gorchakov, R., Garmashova, N., Frolova, E. & Frolov, I. Different types of nsP3-containing protein complexes in Sindbis virus-infected cells. J. Virol. 82, 10088\u201310101 (2008).","journal-title":"J. Virol."},{"key":"42330_CR11","doi-asserted-by":"publisher","first-page":"e0083621","DOI":"10.1128\/JVI.00836-21","volume":"95","author":"F Dominguez","year":"2021","unstructured":"Dominguez, F. et al. NAP1L1 and NAP1L4 binding to hypervariable domain of chikungunya virus nsP3 protein is bivalent and requires phosphorylation. J. Virol. 95, e0083621 (2021).","journal-title":"J. Virol."},{"key":"42330_CR12","doi-asserted-by":"crossref","unstructured":"De Caluwe, L., Arien, K. K. & Bartholomeeusen, K. Host factors and pathways involved in the entry of mosquito-borne alphaviruses. Trends Microbiol. 29, 634\u2013647 (2021).","DOI":"10.1016\/j.tim.2020.10.011"},{"key":"42330_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.virol.2014.09.009","volume":"468-470","author":"S Moller-Tank","year":"2014","unstructured":"Moller-Tank, S. & Maury, W. Phosphatidylserine receptors: enhancers of enveloped virus entry and infection. Virology 468-470, 565\u2013580 (2014).","journal-title":"Virology"},{"key":"42330_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang, R. et al. Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557, 570\u2013574 (2018).","journal-title":"Nature"},{"key":"42330_CR15","doi-asserted-by":"publisher","first-page":"e01681","DOI":"10.1128\/JVI.01681-19","volume":"94","author":"B Gotte","year":"2020","unstructured":"Gotte, B., Utt, A., Fragkoudis, R., Merits, A. & McInerney, G. M. Sensitivity of alphaviruses to G3BP deletion correlates with efficiency of replicase polyprotein processing. J. Virol. 94, e01681\u201319 (2020).","journal-title":"J. Virol."},{"key":"42330_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/v8060166","volume":"8","author":"JJ Fros","year":"2016","unstructured":"Fros, J. J. & Pijlman, G. P. Alphavirus infection: host cell shut-off and inhibition of antiviral responses. Viruses 8, 166 (2016).","journal-title":"Viruses"},{"key":"42330_CR17","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.3389\/fmicb.2017.02652","volume":"8","author":"T Lark","year":"2017","unstructured":"Lark, T., Keck, F. & Narayanan, A. Interactions of alphavirus nsP3 protein with host proteins. Front. Microbiol. 8, 2652 (2017).","journal-title":"Front. Microbiol."},{"key":"42330_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11481-017-9736-7","volume":"12","author":"NK Routhu","year":"2017","unstructured":"Routhu, N. K. & Byrareddy, S. N. Host-virus interaction of ZIKA virus in modulating disease pathogenesis. J. Neuroimmune Pharmacol. 12, 219\u2013232 (2017).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"42330_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-019-1578-4","volume":"574","author":"L Meertens","year":"2019","unstructured":"Meertens, L. et al. FHL1 is a major host factor for chikungunya virus infection. Nature 574, 259\u2013263 (2019).","journal-title":"Nature"},{"key":"42330_CR20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.nmd.2014.02.002","volume":"24","author":"AT Bertrand","year":"2014","unstructured":"Bertrand, A. T., B\u00f6nnemann, C. G. & Bonne, G. 199th ENMC international workshop: FHL1 related myopathies, June 7-9, 2013, Naarden, The Netherlands. Neuromuscul. Disord. 24, 453\u2013462 (2014). & consortium, F. H. L.","journal-title":"Neuromuscul. Disord."},{"key":"42330_CR21","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1093\/hmg\/ddt412","volume":"23","author":"AA Domenighetti","year":"2014","unstructured":"Domenighetti, A. A. et al. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice. Hum. Mol. Genet. 23, 209\u2013225 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"42330_CR22","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1093\/hmg\/dds157","volume":"21","author":"FW Friedrich","year":"2012","unstructured":"Friedrich, F. W. et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum. Mol. Genet. 21, 3237\u20133254 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"42330_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.ajhg.2009.07.015","volume":"85","author":"L Gueneau","year":"2009","unstructured":"Gueneau, L. et al. Mutations of the FHL1 gene cause Emery-Dreifuss muscular dystrophy. Am. J. Hum. Genet. 85, 338\u2013353 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"42330_CR24","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/s10038-019-0627-z","volume":"64","author":"Z Hu","year":"2019","unstructured":"Hu, Z. et al. FHL1-related clinical, muscle MRI and genetic features in six Chinese patients with reducing body myopathy. J. Hum. Genet. 64, 919\u2013926 (2019).","journal-title":"J. Hum. Genet."},{"key":"42330_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s00439-017-1804-9","volume":"136","author":"N Pillar","year":"2017","unstructured":"Pillar, N. et al. A rare variant in the FHL1 gene associated with X-linked recessive hypoparathyroidism. Hum. Genet. 136, 835\u2013845 (2017).","journal-title":"Hum. Genet."},{"key":"42330_CR26","doi-asserted-by":"publisher","first-page":"27083","DOI":"10.1074\/jbc.274.38.27083","volume":"274","author":"S Brown","year":"1999","unstructured":"Brown, S. et al. Characterization of two isoforms of the skeletal muscle LIM protein 1, SLIM1. Localization of SLIM1 at focal adhesions and the isoform slimmer in the nucleus of myoblasts and cytoplasm of myotubes suggests distinct roles in the cytoskeleton and in nuclear-cytoplasmic communication. J. Biol. Chem. 274, 27083\u201327091 (1999).","journal-title":"J. Biol. Chem."},{"key":"42330_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0378-1119(99)00125-0","volume":"232","author":"WK Greene","year":"1999","unstructured":"Greene, W. K., Baker, E., Rabbitts, T. H. & Kees, U. R. Genomic structure, tissue expression and chromosomal location of the LIM-only gene, SLIM1. Gene 232, 203\u2013207 (1999).","journal-title":"Gene"},{"key":"42330_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000015643","volume":"90","author":"A Krempler","year":"2000","unstructured":"Krempler, A., Kollers, S., Fries, R. & Brenig, B. Isolation and characterization of a new FHL1 variant (FHL1C) from porcine skeletal muscle. Cytogenet. Cell Genet. 90, 106\u2013114 (2000).","journal-title":"Cytogenet. Cell Genet."},{"key":"42330_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ejmg.2015.02.003","volume":"58","author":"AE Pen","year":"2015","unstructured":"Pen, A. E. et al. A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology. Eur. J. Med. Genet. 58, 222\u2013229 (2015).","journal-title":"Eur. J. Med. Genet."},{"key":"42330_CR30","doi-asserted-by":"publisher","first-page":"e01672","DOI":"10.1128\/JVI.01672-20","volume":"95","author":"T Lukash","year":"2020","unstructured":"Lukash, T. et al. Structural and functional characterization of host FHL1 protein interaction with hypervariable domain of chikungunya virus nsP3 protein. J. Virol. 95, e01672\u201320 (2020).","journal-title":"J. Virol."},{"key":"42330_CR31","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1128\/JVI.00439-14","volume":"88","author":"MD Panas","year":"2014","unstructured":"Panas, M. D., Ahola, T. & McInerney, G. M. The C-terminal repeat domains of nsP3 from the Old World alphaviruses bind directly to G3BP. J. Virol. 88, 5888\u20135893 (2014).","journal-title":"J. Virol."},{"key":"42330_CR32","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1099\/vir.0.81406-0","volume":"87","author":"SE Galbraith","year":"2006","unstructured":"Galbraith, S. E., Sheahan, B. J. & Atkins, G. J. Deletions in the hypervariable domain of the nsP3 gene attenuate Semliki Forest virus virulence. J. Gen. Virol. 87, 937\u2013947 (2006).","journal-title":"J. Gen. Virol."},{"key":"42330_CR33","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1128\/JVI.03453-13","volume":"88","author":"D Hallengard","year":"2014","unstructured":"Hallengard, D. et al. Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL\/6 mice. J. Virol. 88, 2858\u20132866 (2014).","journal-title":"J. Virol."},{"key":"42330_CR34","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1086\/587841","volume":"197","author":"BA Lidbury","year":"2008","unstructured":"Lidbury, B. A. et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J. Infect. Dis. 197, 1585\u20131593 (2008).","journal-title":"J. Infect. Dis."},{"key":"42330_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1128\/JVI.80.2.737-749.2006","volume":"80","author":"TE Morrison","year":"2006","unstructured":"Morrison, T. E. et al. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J. Virol. 80, 737\u2013749 (2006).","journal-title":"J. Virol."},{"key":"42330_CR36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/art.30112","volume":"63","author":"A Zaid","year":"2011","unstructured":"Zaid, A., Rulli, N. E., Rolph, M. S., Suhrbier, A. & Mahalingam, S. Disease exacerbation by etanercept in a mouse model of alphaviral arthritis and myositis. Arthritis Rheum. 63, 488\u2013491 (2011).","journal-title":"Arthritis Rheum."},{"key":"42330_CR37","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/emmm.201200213","volume":"4","author":"YW Kam","year":"2012","unstructured":"Kam, Y. W. et al. Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein. EMBO Mol. Med. 4, 330\u2013343 (2012).","journal-title":"EMBO Mol. Med."},{"key":"42330_CR38","doi-asserted-by":"publisher","first-page":"13878","DOI":"10.1128\/JVI.02666-13","volume":"87","author":"DW Hawman","year":"2013","unstructured":"Hawman, D. W. et al. Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J. Virol. 87, 13878\u201313888 (2013).","journal-title":"J. Virol."},{"key":"42330_CR39","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.4049\/jimmunol.1300304","volume":"190","author":"FM Lum","year":"2013","unstructured":"Lum, F. M. et al. An essential role of antibodies in the control of Chikungunya virus infection. J. Immunol. 190, 6295\u20136302 (2013).","journal-title":"J. Immunol."},{"key":"42330_CR40","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.tim.2015.09.006","volume":"23","author":"SS Foo","year":"2015","unstructured":"Foo, S. S., Reading, P. C., Jaillon, S., Mantovani, A. & Mahalingam, S. Pentraxins and Collectins: Friend or Foe during Pathogen Invasion? Trends Microbiol. 23, 799\u2013811 (2015).","journal-title":"Trends Microbiol."},{"key":"42330_CR41","doi-asserted-by":"publisher","first-page":"e1004649","DOI":"10.1371\/journal.ppat.1004649","volume":"11","author":"SS Foo","year":"2015","unstructured":"Foo, S. S. et al. Role of pentraxin 3 in shaping arthritogenic alphaviral disease: from enhanced viral replication to immunomodulation. PLoS Pathog. 11, e1004649 (2015).","journal-title":"PLoS Pathog."},{"key":"42330_CR42","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1083\/jcb.200804077","volume":"183","author":"BS Cowling","year":"2008","unstructured":"Cowling, B. S. et al. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy. J. Cell Biol. 183, 1033\u20131048 (2008).","journal-title":"J. Cell Biol."},{"key":"42330_CR43","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1086\/323603","volume":"184","author":"AM Kesson","year":"2001","unstructured":"Kesson, A. M. & King, N. J. Transcriptional regulation of major histocompatibility complex class I by flavivirus West Nile is dependent on NF-kappaB activation. J. Infect. Dis. 184, 947\u2013954 (2001).","journal-title":"J. Infect. Dis."},{"key":"42330_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/sj.icb.7100012","volume":"85","author":"NJ King","year":"2007","unstructured":"King, N. J. et al. Immunopathology of flavivirus infections. Immunol. Cell Biol. 85, 33\u201342 (2007).","journal-title":"Immunol. Cell Biol."},{"key":"42330_CR45","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1099\/0022-1317-69-10-2535","volume":"69","author":"NJ King","year":"1988","unstructured":"King, N. J. & Kesson, A. M. Interferon-independent increases in class I major histocompatibility complex antigen expression follow flavivirus infection. J. Gen. Virol. 69, 2535\u20132543 (1988).","journal-title":"J. Gen. Virol."},{"key":"42330_CR46","doi-asserted-by":"publisher","first-page":"e1006748","DOI":"10.1371\/journal.ppat.1006748","volume":"13","author":"KC Haist","year":"2017","unstructured":"Haist, K. C., Burrack, K. S., Davenport, B. J. & Morrison, T. E. Inflammatory monocytes mediate control of acute alphavirus infection in mice. PLoS Pathog. 13, e1006748 (2017).","journal-title":"PLoS Pathog."},{"key":"42330_CR47","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1128\/JVI.02034-14","volume":"89","author":"W Chen","year":"2015","unstructured":"Chen, W. et al. Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by chikungunya virus infection. J. Virol. 89, 581\u2013593 (2015).","journal-title":"J. Virol."},{"key":"42330_CR48","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1073\/pnas.1318859111","volume":"111","author":"W Chen","year":"2014","unstructured":"Chen, W. et al. Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. Proc. Natl. Acad. Sci. USA 111, 6040\u20136045 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"42330_CR49","doi-asserted-by":"publisher","first-page":"625711","DOI":"10.3389\/fcell.2021.625711","volume":"9","author":"G Nowee","year":"2021","unstructured":"Nowee, G. et al. A tale of 20 alphaviruses; inter-species diversity and conserved interactions between viral non-structural protein 3 and stress granule proteins. Front. Cell Dev. Biol. 9, 625711 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"42330_CR50","doi-asserted-by":"publisher","first-page":"e00841","DOI":"10.1128\/JVI.00841-19","volume":"94","author":"LE Cook","year":"2019","unstructured":"Cook, L. E. et al. Distinct roles of interferon alpha and beta in controlling chikungunya virus replication and modulating neutrophil-mediated inflammation. J. Virol. 94, e00841\u201319 (2019).","journal-title":"J. Virol."},{"key":"42330_CR51","doi-asserted-by":"publisher","first-page":"e0028922","DOI":"10.1128\/mbio.00289-22","volume":"13","author":"X Liu","year":"2022","unstructured":"Liu, X. et al. Interleukin-17 contributes to chikungunya virus-induced disease. mBio 13, e0028922 (2022).","journal-title":"mBio"},{"key":"42330_CR52","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jir470","volume":"204","author":"NE Rulli","year":"2011","unstructured":"Rulli, N. E. et al. Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. J. Infect. Dis. 204, 1026\u20131030 (2011).","journal-title":"J. Infect. Dis."},{"key":"42330_CR53","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1002\/art.38090","volume":"65","author":"LJ Herrero","year":"2013","unstructured":"Herrero, L. J. et al. Macrophage migration inhibitory factor receptor CD74 mediates alphavirus-induced arthritis and myositis in murine models of alphavirus infection. Arthritis Rheum. 65, 2724\u20132736 (2013).","journal-title":"Arthritis Rheum."},{"key":"42330_CR54","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.4049\/jimmunol.1701154","volume":"200","author":"JH DeLong","year":"2018","unstructured":"DeLong, J. H. et al. Cytokine- and TCR-Mediated Regulation of T Cell Expression of Ly6C and Sca-1. J. Immunol. 200, 1761\u20131770 (2018).","journal-title":"J. Immunol."},{"key":"42330_CR55","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/eji.201040760","volume":"41","author":"A Hanninen","year":"2011","unstructured":"Hanninen, A., Maksimow, M., Alam, C., Morgan, D. J. & Jalkanen, S. Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes. Eur. J. Immunol. 41, 634\u2013644 (2011).","journal-title":"Eur. J. Immunol."},{"key":"42330_CR56","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1159\/000490585","volume":"10","author":"Y Kusaka","year":"2018","unstructured":"Kusaka, Y. et al. Potential Role of Gr-1+ CD8+ T lymphocytes as a source of interferon-gamma and M1\/M2 polarization during the acute phase of murine legionella pneumophila pneumonia. J. Innate Immun. 10, 328\u2013338 (2018).","journal-title":"J. Innate Immun."},{"key":"42330_CR57","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3389\/fcell.2019.00212","volume":"7","author":"Y Yan","year":"2019","unstructured":"Yan, Y. et al. CCL19 and CCR7 expression, signaling pathways, and adjuvant functions in viral infection and prevention. Front. Cell Dev. Biol. 7, 212 (2019).","journal-title":"Front. Cell Dev. Biol."},{"key":"42330_CR58","doi-asserted-by":"publisher","first-page":"S488","DOI":"10.1093\/infdis\/jiw271","volume":"214","author":"JH Erasmus","year":"2016","unstructured":"Erasmus, J. H., Rossi, S. L. & Weaver, S. C. Development of vaccines for chikungunya fever. J. Infect. Dis. 214, S488\u2013S496 (2016).","journal-title":"J. Infect. Dis."},{"key":"42330_CR59","doi-asserted-by":"publisher","first-page":"e01970","DOI":"10.1128\/mBio.01970-16","volume":"8","author":"A Taylor","year":"2017","unstructured":"Taylor, A. et al. Mutation of the N-terminal region of chikungunya virus capsid protein: implications for vaccine design. mBio 8, e01970\u201316 (2017).","journal-title":"mBio"},{"key":"42330_CR60","doi-asserted-by":"publisher","first-page":"954811","DOI":"10.3389\/fcimb.2022.954811","volume":"12","author":"A Nogales","year":"2022","unstructured":"Nogales, A., DeDiego, M. L. & Martinez-Sobrido, L. Live attenuated influenza A virus vaccines with modified NS1 proteins for veterinary use. Front. Cell Infect. Microbiol. 12, 954811 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"42330_CR61","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","volume":"92","author":"KL Mansfield","year":"2011","unstructured":"Mansfield, K. L. et al. Flavivirus-induced antibody cross-reactivity. J. Gen. Virol. 92, 2821\u20132829 (2011).","journal-title":"J. Gen. Virol."},{"key":"42330_CR62","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4049\/jimmunol.1801054","volume":"202","author":"LD Estrada","year":"2019","unstructured":"Estrada, L. D. & Schultz-Cherry, S. Development of a universal influenza vaccine. J. Immunol. 202, 392\u2013398 (2019).","journal-title":"J. Immunol."},{"key":"42330_CR63","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/COH.0000000000000360","volume":"12","author":"M Pancera","year":"2017","unstructured":"Pancera, M., Changela, A. & Kwong, P. D. How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design. Curr. Opin. HIV AIDS 12, 229\u2013240 (2017).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"42330_CR64","doi-asserted-by":"publisher","first-page":"e00117","DOI":"10.1128\/JVI.00117-21","volume":"95","author":"C Jacob-Dolan","year":"2021","unstructured":"Jacob-Dolan, C. et al. Coronavirus-specific antibody cross reactivity in rhesus macaques following SARS-CoV-2 vaccination and infection. J. Virol. 95, e00117\u2013e00121 (2021).","journal-title":"J. Virol."},{"key":"42330_CR65","doi-asserted-by":"publisher","first-page":"e70330","DOI":"10.7554\/eLife.70330","volume":"10","author":"M Grobben","year":"2021","unstructured":"Grobben, M. et al. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination. Elife 10, e70330 (2021).","journal-title":"Elife"},{"key":"42330_CR66","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.vaccine.2018.12.005","volume":"37","author":"I Vojtek","year":"2019","unstructured":"Vojtek, I., Buchy, P., Doherty, T. M. & Hoet, B. Would immunization be the same without cross-reactivity? Vaccine 37, 539\u2013549 (2019).","journal-title":"Vaccine"},{"key":"42330_CR67","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1126\/science.1185181","volume":"328","author":"W Dejnirattisai","year":"2010","unstructured":"Dejnirattisai, W. et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328, 745\u2013748 (2010).","journal-title":"Science"},{"key":"42330_CR68","doi-asserted-by":"publisher","first-page":"4430","DOI":"10.1016\/j.cell.2021.07.033","volume":"184","author":"LE Williamson","year":"2021","unstructured":"Williamson, L. E. et al. Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress. Cell 184, 4430\u20134446.e4422 (2021).","journal-title":"Cell"},{"key":"42330_CR69","doi-asserted-by":"publisher","first-page":"e1008743","DOI":"10.1371\/journal.ppat.1008743","volume":"16","author":"JM Fox","year":"2020","unstructured":"Fox, J. M. et al. A cross-reactive antibody protects against Ross River virus musculoskeletal disease despite rapid neutralization escape in mice. PLoS Pathog. 16, e1008743 (2020).","journal-title":"PLoS Pathog."},{"key":"42330_CR70","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","volume":"333","author":"I Hickie","year":"2006","unstructured":"Hickie, I. et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ 333, 575 (2006).","journal-title":"BMJ"},{"key":"42330_CR71","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0378-1119(98)00302-3","volume":"216","author":"SM Lee","year":"1998","unstructured":"Lee, S. M. et al. Chromosomal mapping, tissue distribution and cDNA sequence of four-and-a-half LIM domain protein 1 (FHL1). Gene 216, 163\u2013170 (1998).","journal-title":"Gene"},{"key":"42330_CR72","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/978-1-4939-9454-0_12","volume":"1989","author":"TM Ashhurst","year":"2019","unstructured":"Ashhurst, T. M., Cox, D. A., Smith, A. L. & King, N. J. C. Analysis of the murine bone marrow hematopoietic system using mass and flow cytometry. Methods Mol. Biol. 1989, 159\u2013192 (2019).","journal-title":"Methods Mol. Biol."},{"key":"42330_CR73","doi-asserted-by":"publisher","first-page":"861","DOI":"10.21105\/joss.00861","volume":"3","author":"L McInnes","year":"2018","unstructured":"McInnes, L., Healy, J., Saul, N. & Grossberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).","journal-title":"J. Open Source Softw."},{"key":"42330_CR74","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/v10050226","volume":"10","author":"M Mutso","year":"2018","unstructured":"Mutso, M. et al. Mutation of CD2AP and SH3KBP1 binding motif in alphavirus nsP3 hypervariable domain results in attenuated virus. Viruses 10, 226 (2018).","journal-title":"Viruses"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42330-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42330-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42330-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T11:16:54Z","timestamp":1700047014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-42330-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,26]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["42330"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-42330-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,26]]},"assertion":[{"value":"13 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6605"}}